Search Within

Maura N Dickler

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (61)
  2. Journal Article (43)
  3. Book Section (1)
Groups
  1. Epidemiology and Biostatistics (105)
  2. Survivorship Research (97)
  3. Department of Medicine (96)
  4. Solid Tumor Oncology Division (96)
  5. Breast Medicine Service (95)
  6. Population Sciences Research Program (83)

More Groups

People
  1. Clifford Hudis (64)
  2. Shari Goldfarb (51)
  3. Larry Norton (40)
  4. Sujata Patil (35)
  5. Chau Dang (28)
  6. Diana Lake (24)

More People

Years
  1. 2021 (1)
  2. 2020 (5)
  3. 2019 (2)
  4. 2018 (8)
  5. 2017 (10)
  6. 2016 (5)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Cancer Research (21)
  3. Breast Cancer Research and Treatment (7)
  4. Clinical Cancer Research (7)
  5. Journal of Sexual Medicine (7)
  6. Fertility and Sterility (5)

More Publications

Publishers
  1. American Association for Cancer Research (30)
  2. American Society of Clinical Oncology (28)
  3. Elsevier Inc. (11)
  4. Springer (9)
  5. Elsevier Science, Inc. (5)
  6. Oxford University Press (5)

More Publishers

Results (105)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status
    Journal Article

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Cancer (2016)

    Fulltext@MSK | Save
  • Menstruation Is an unreliable surrogate in the assessment of ovarian damage by chemotherapy: A prospective longitudinal study with AMH levels as the gold standard
    Meeting Abstract

    Bedoschi, G.; Goldfarb, S.; Quistorff, J.; Goswami, S.; Moy, F.; Dickler, M.; Oktay, K.
    Fertility and Sterility (2015)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Oncotype DX in BRCA-associated vs. sporadic breast cancers: Differences based on germline mutation status and potential implications for adjuvant systemic therapy (AST)
    Meeting Abstract

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The impact of adjuvant breast cancer (BC) chemotherapy on ovarian reserve and menses
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M. E.; Moy, F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I, open-label study evaluating the safety and tolerability of LJM716, BYL719 and trastuzumab in patients with metastatic HER2+ breast cancer
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Ulaner, G.; Zamora, S.; Sterlin, V.; Iasonos, A.; Dickler, M. N.; Moynahan, M. E.; Hudis, C. A.; Baselga, J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of breast cancer treatment with adjuvant chemotherapy or tamoxifen alone on ovarian reserve
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M.; Moy, F.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Sources and types of online information that breast cancer patients read and discuss with their doctors
    Journal Article

    Maloney, E. K.; D'Agostino, T. A.; Heerdt, A.; Dickler, M.; Li, Y.; Ostroff, J. S.; Bylund, C. L.
    Palliative and Supportive Care (2015)

    Fulltext@MSK | Save